TipRanks
Go Ultimate55% OFF

Jonathan Symonds Insider Profile

4 Followers

Jonathan Symonds, Director at Rubius Therapeutics, holds 25.00K shares in Rubius Therapeutics (Ticker: RUBY). Most recently, Jonathan Symonds Bought 25,000 shares of Rubius Therapeutics on Jul 23, 2018 for an estimated value of $575.00K.

Jonathan Symonds's Trading History

RUBY
Rubius Therapeutics
Jul 23, 2018―Informative Buy575.00K$1.43K
RUBY
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Jul 23, 2018Informative Buy$575.00K25,000$23.00―

You May Also Like

Jonathan Symonds insider profile FAQ

What stocks does Jonathan Symonds hold?
Jonathan Symonds holds: RUBY stocks.
What was Jonathan Symonds’s latest transaction?
Jonathan Symonds’s latest transaction was an Informative Buy of $575.00K.
What is Jonathan Symonds's role in Rubius Therapeutics?
Jonathan Symonds's role in Rubius Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.